Xylem Inc. (NYSE:XYL) Stake Decreased by Boston Research & Management Inc.

Boston Research & Management Inc. lessened its stake in shares of Xylem Inc. (NYSE:XYL) by 1.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 64,476 shares of the industrial products company’s stock after selling 1,166 shares during the period. Xylem comprises about 2.2% of Boston Research & Management Inc.’s holdings, making the stock its 9th biggest position. Boston Research & Management Inc.’s holdings in Xylem were worth $8,744,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. EverSource Wealth Advisors LLC lifted its position in shares of Xylem by 68.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after buying an additional 77 shares during the last quarter. Mark Sheptoff Financial Planning LLC bought a new stake in Xylem in the 2nd quarter valued at about $33,000. Blue Trust Inc. lifted its holdings in Xylem by 1,185.7% during the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock valued at $35,000 after purchasing an additional 249 shares during the last quarter. FinTrust Capital Advisors LLC boosted its position in Xylem by 170.9% during the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after purchasing an additional 200 shares during the period. Finally, Hazlett Burt & Watson Inc. increased its stake in shares of Xylem by 184.9% in the first quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after purchasing an additional 220 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Stock Down 1.1 %

Shares of NYSE XYL opened at $134.81 on Friday. The company has a current ratio of 1.85, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. The business has a 50-day moving average of $133.68 and a 200-day moving average of $134.13. The firm has a market capitalization of $32.74 billion, a price-to-earnings ratio of 47.98, a PEG ratio of 2.34 and a beta of 1.04. Xylem Inc. has a 12 month low of $87.59 and a 12 month high of $146.08.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. The business had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.14 billion. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The business’s quarterly revenue was up 26.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.98 EPS. Sell-side analysts expect that Xylem Inc. will post 4.26 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 26th. Investors of record on Thursday, August 29th will be paid a $0.36 dividend. The ex-dividend date of this dividend is Thursday, August 29th. This represents a $1.44 dividend on an annualized basis and a yield of 1.07%. Xylem’s dividend payout ratio is presently 51.25%.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Oppenheimer upped their price target on shares of Xylem from $147.00 to $152.00 and gave the company an “outperform” rating in a research note on Friday, May 31st. Stifel Nicolaus increased their target price on Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday, July 31st. Royal Bank of Canada lifted their price target on Xylem from $160.00 to $163.00 and gave the company an “outperform” rating in a research report on Wednesday, July 31st. Robert W. Baird increased their price objective on Xylem from $155.00 to $170.00 and gave the stock an “outperform” rating in a report on Wednesday, July 31st. Finally, UBS Group initiated coverage on Xylem in a research note on Tuesday, August 13th. They issued a “buy” rating and a $165.00 target price for the company. Five analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $147.54.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.